Lapatinib in Combination With Vinorelbine

NCT01013740 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Vinorelbine
DRUG: Lapatinib
DRUG: Capecitabine

Sponsor

Novartis Pharmaceuticals